Molina Healthcare Inc · NYSE:MOH

Molina Healthcare — Investor Day (November 2024)

88 slides from Molina Healthcare's investor day presentation, Nov 8, 2024

  1. Slide 1: Investor Day 2024: Value Creation: The Next Wave

    @e BRRMOLINA HEALTHCARE Investor Day 2024 Value Creation: The Next Wave November 8, 2024

  2. Slide 2: Value Creation: The Next Wave

    Value Creation: The Next Wave Topic eaker Welcome and Introduction Jeff Geyer Sustaining Profitable Growth Joe Zubretsky Compeliing Financial Profile Mark Keim Joe Zubretsky aaa Mark Keim Jim Woys

  3. Slide 3: Cautionary Statement

    Cautionary Statement Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This presentation and the accompanying oral remarks include forward-looking statements regarding, without linitation, the Company's growth ‘Strategy and long-term growth rate, embedded earnings and

  4. Slide 4: Sustaining Profitable Growth

    * em MOLINA nh HEALTHCARE Sustaining Profitable Growth Joe Zubretsky President and Chief Executive Officer

  5. Slide 5: Our Historical Performance

    Our Historical Performance Our track record sets the foundation for our long-terms targets What We Said We Would Do What We Delivered What We Will Do (Prior Long-Term Targets) (2019 10 20246) (20246 t0 2027) — 13% - 15% Premium CAGR ~ Organic growth current footprint ~ Strategic initiatives ~ Accret

  6. Slide 6: Performance Outlook

    Performance Outlook Our strategy will produce sustainable, profitable growth and industry leading margins What We Will Do ~ The Next 3 Years Premium Revenue Growth Pretax Margin T% - 9% 87.5% - 88.5% 11% - 13% Organic Growth Medical Cost Ratio Earnings Growth Zs <T%h ~2% Acquisitions G&A Ratio Share

  7. Slide 7: Sustaining Profitable Growth

    Sustaining Profitable Growth ef Value Creating Franchise The Growth Model @ Retrospective fi Operating Excellence Current Environment Performance Outlook

  8. Slide 8: Value Creating Franchise

    Value Creating Franchise

  9. Slide 9: The Molina Franchise

    The Molina Franchise Aleading pure-play, government-sponsored managed care franchise with depth, EAR FORTUNE 128 Ranking 5.7M Members YE 2024 a. , breadth, and scale 9% 3 Products Medicaid, Medicare ‘and Marketplace

  10. Slide 10: Diversified and Balanced Portfolio

    Diversified and Balanced Portfolio a, Geographically diversified portfolio of complementary product segments Synergistic Medicare and Marketplace Well Diversified 21 State Portfolio Segments Complement Medicaid 6% Marketplace 79% Medicaid Percent of Total Premium Revenue WE stores [510% M10

  11. Slide 11: Portfolio Synergies

    Portfolio Synergies Synergistic product segments provide member continuity and leverage common capabilities 400. Marketplace {ow bat) = 2 2 ci : : 5 10 Continuity for = 138 “age ins” and = Integration 3 100 Requirements £ Age 65

  12. Slide 12: Retrospective

    Retrospective

  13. Slide 13: Long-Term Value Creation

    Long-Term Value Creation Aproven track record of industry-leading profitable growth and shareholder value creation Revenue Growth Adjusted EPS Growth Total Shareholder Return (201910 2024) (201910 2024) (2019 t0 Current) 313% vs. ~69% 19% 15% 12% iiihyouny Moo Peers iiliyouny C0 Peers aiibyouy MoO P

  14. Slide 14: Premium Revenue Growth

    Premium Revenue Growth y 19% trailing five-year CAGR was well balanced between organic growth and M&A, more than doubling the size of the Company while maintaining industry leading margins nS Bions Organic $16 Current Footprint Strategic Initiatives. Maa 2024 Guidance

  15. Slide 15: Organic Premium Revenue Growth

    Organic Premium Revenue Growth Total organic premium growth of 11% was above the high end of our long-term range led by the Medicaid flagship Prior 2019 - 20246 Long-term Target Achieved = = 12%

  16. Slide 16: RFP Wins and Accretive Acquisitions

    RFP Wins and Accretive Acquisitions a A successful history of retaining existing contracts and delivering new store growth through RFP wins and accretive acquisitions ‘Within Current Footprint '$7B Premium Realized 2019-20246 ‘$95 Premium Realized 2019-2024 & SS é « L : eee % Gara. afew When $3.58 P

  17. Slide 17: Adjusted EPS Growth

    Adjusted EPS Growth YI Adjusted EPS growth is achieved through current footprint and new store embedded earnings. $6.00 remains for 2025 through 2027. 22350 $20.88 Organic growth sr792 inca $13.54 RealzedNew $10.67 my Soe 2020 2021 202 New Store Realized ($1.00) ($1.50) ($1.00) ($2.00) New Store Adt

  18. Slide 18: Current Environment

    Current Environment

  19. Slide 19: Government Managed Care Market

    Government Managed Care Market My Addressable markets exceed $750 billion in annual spend with attractive, profitable growth opportunities Managed Medicaid Medicare Duals Marketplace 58M $1508 $1488 21M ‘Spend,

  20. Slide 20: Molina Market Share Profile

    Molina Market Share Profile " Market shares across all segments are large enough for scale and relevancy but allow for substantial growth opportunity | Medicaid Medicare Duals Marketplace National Market Share #4 Nationally +¥8 Nationally Top 15 Nationally Ce ma Average State Manes SS - -s

  21. Slide 21: Political and Regulatory Environment

    Pol ical and Regulatory Environment ey We focus on the possible policy changes and what it would take to make them in any political scenario Policies in Focus Work requirements Dual-eligible integration Medicaid expansion | 2) Federal legislation & Budget Reconciliation Risk adustment & Stars Dual-e

  22. Slide 22: Highly Attractive Business Mix

    Highly Attractive Business Mix My The current environment creates a very favorable outlook for all Molina segments Medicare Duals Environment — Duals growth projected to exceed traditional Medicare Medicaid Environment — Actuarially sound rates — Expansion of entitlement — Shift towards integration

  23. Slide 23: The Growth Model

    The Growth Model Medicaid / Medicare / Marketplace / Accretive M&A

  24. Slide 24: Long-Term Premium Revenue Growth Targets

    Long-Term Premium Revenue Growth Targets Strong, balanced organic growth complemented by a disciplined acquisition strategy Organic Growth | Marketplace 5% with Optionality Organic Acquisitions Total

  25. Slide 25: The Growth Model

    The Growth Model The growth model is well-balanced between organic drivers and accretive M&A. ~23 Organic ~1/3 Accretive M&A _—————S EE Pe 1% -13% Industry Leading Bolt-ons in Care Guitte Lines! Profitable Growth, Strategic Initiatives 3% -5% New Contracts Market Share Current Footprint 4% Market Gr

  26. Slide 26: 2027 Premium Revenue Target

    2027 Premium Revenue Target a Premium revenue growth target of 11% - 13% is well-balanced and maintains the trajectory to achieve the previous outlook of $46 billion in 2026 $52 to ~' In $ Bittons Organic - 7" = ‘Current Footprint Strategic Initiatives. M&A

  27. Slide 27: 2027 Premium Revenue Target

    2027 Premium Revenue Target Of the $9 to $12 billion of premium revenue growth from strategic initiatives and M&A, approximately 50% has already been secured $52 to ~' In $ Bilions ‘Organic - ” = $5 currently in-flight: ConnectiCare: $1.48, TX Star CHIP: $1.38. Mi, OH, NA Duals: $188, TX Stars: $068

  28. Slide 28: Medicaid

    Medicaid

  29. Slide 29: Medicaid Long-Term Growth

    %, ee Medicaid Long-Term Growth ~ Long-term growth target of 7% - 9% is driven by the current footprint, in-flight initiatives, and projected strategic initiatives Strategic Initiative Opportunity Organic Premium Revenue Opportunity Win new RFP States s:0) [EB irerease market share @ [ED Pursue care

  30. Slide 30: Sizing the New State RFP Opportunity

    Sizing the New State RFP Opportunity ee New state RFPs yield $30 billion of revenue opportunity by 2027 with $50 billion in active procurement cycle Total Contract Value Projected Market Share ~15% 2027 Revenue Opportunity ~$5B m kad

  31. Slide 31: Molina's Proven RFP Formula

    Molina’s Proven RFP Formula Yer: Our RFP approach is built on execution of proven business development capabilities and a track record of operational excellence Target Selection Criteria Formula Components : . Effective ground game that starts Size and duration of contract ia sears Geto AEE Strength

  32. Slide 32: Increase Market Share

    Increase Market Share Sem Focus on fundamental operating tactics will drive significant market share gain opportunity ~ Engage providers to drive membership loyalty — Improve quality scores to drive auto assignment ~ Increase voluntary enrollment through community presence and awareness ~ Redetermin

  33. Slide 33: Pursue Carve-in Opportunities

    Pursue Carve-in Opportunities Ne Maximize carve-in opportunities as states increasingly leverage managed cares capabilities Projected Contracts and Value L188 Carvein Opportunities Advocate for and pursue carve-in programs za Win LTSS opportunities within our current Medicaid footprint Foster care C

  34. Slide 34: Medicare

    Medicare

  35. Slide 35: Medicare Long-Term Growth

    &, Se SS Medicare Long-Term Growth Long-term growth target of 12% - 14% is driven by the current footprint, in-flight initiatives, and projected strategic initiatives Strategic Initiative Opportunity Organic Premium Revenue Opportunity 0% -2% 12% - 14% Maximize MMP conversions into HIDE/FIDE B Incre

  36. Slide 36: Molina Strategic Position

    Se Molina Strategic Position Our Medicare segment is largely comprised of Duals products with significant overlap of Medicaid plans in 16 states as we leverage our Medicaid footprint 20246 Product States | Member 6) MMP 5 50 $18 DSNP / HIDE / FIDE 15 120 $3.0 Total Duals 16 170 $4.8 Non-Duals. 15 80

  37. Slide 37: Increasing Duals Alignment

    ee Increasing Duals Alignment we CMS and state policies are increasingly focused on alignment of Medicaid and Medicare products. Both scenarios are projected to have attractive high-growth markets, cms — The 2026 Final Rule encourages increased integration of Medicare and Medicaid Guidance ~ The new

  38. Slide 38: Maximize MMP Conversion into HIDE / FIDE

    SS Maximize MMP Conversion into HIDE / FIDE “ We have begun to transition our MMP members into HIDE or FIDE product with early success in Michigan and Ohio ~ Successfully procured 2 states (MI & OH) — 4 remaining state-wide procurement where Molina carries strength of incumbency — 2 remaining states

  39. Slide 39: Increase Duals Market Share

    Increase Duals Market Share Focus on fundamental operating tactics, product design, distribution expansion and pricing discipline will drive significant market share opportunity r fie 1% ~$0.78 Incremental market 2027 Revenue Opportunity 2 share in current footprint y 2% > ~$0.38 Target market share

  40. Slide 40: Marketplace

    Marketplace

  41. Slide 41: Marketplace Long-Term Growth

    S Long-term growth target of ~5% is driven by the current footprint with optionality from projected initiatives Strategic Initiative Opportunity Organic Premium Revenue Opportunity Increase market share in current footprint Optionality Marketplace Long-Term Growth Expand service areas in 5% current

  42. Slide 42: Strong Market Growth

    ie Strong Market Growth “SS Several market dynamics have driven substantial growth Market Growth Market Dynamics clas — Enhanced subsidies were extended through 2025 — Year-round Special Enrollment Period for under 150% FPL was made permanent — Members transitioned from Medicaid throughout Redetermi

  43. Slide 43: Market Outlook

    Market Outlook i Continued organic growth expected to offset disenrollments from the potential expiration of enhanced subsidies Membership Outlook Subst Dyas — Outlook assumes ~20% of enrollees could exit the market if enhanced subsidies expire — Additional buy-downs to Bronze plans vary based on ge

  44. Slide 44: Increase Market Share

    Increase Market Share oe Focus on fundamental operating tactics, product design, distribution expansion and pricing discipline will drive significant market share opportunity share in current footprint BS 6% ~$1.68 Incremental market 2027 Revenue ‘Opportunity 4% ~$0.4B Target market share in 2027 Re

  45. Slide 45: Accretive M&A

    Accretive M&A

  46. Slide 46: M&A Platform

    eae me M&A Platform “S MBA is a key element of the long-term premium growth targets |) ‘Ample excess cash flow internally funds BD Previously announced purchase prices acquisitions are highly capital efficient B We buy long-dated, stable revenue BD Underperforming properties yield streams accretion

  47. Slide 47: M&A Pipeline

    M&A Pipeline “is The acquisition pipeline remains robust with many remaining opportunities SER EST AEE Numerous acquisition opportunities are actionable E> Turnarounds provide attractive economics Capitated risk, not services or vertical integration 2027 requires $6 billion of acquired revenue. $1.4

  48. Slide 48: M&A Track Record

    as M&A Track Record — Seven completed transactions sequenced for manageable integration and one transaction pending Magellan Afinity ‘AgeWell Bright 3 Complete Care Health Plan New York Healthcare 8 a 3 vaca Cigna Te My oh fourCare igna Texas ly Choice : é Health Plan Medicaid Wisconsin Conners 2 Yo

  49. Slide 49: M&A Metrics

    M&A Metrics Recent transactions were purchased at capital efficient prices and yield accretion from sweat equity Up Transactions completed ~5.5X Average EV/EBITDA ~$9 Billion Revenue Acquired < 25% Average Purchase Muttiple as % of Premium ~$2.3B Capital Deployed ~$4.00 Embedded Earnings Harvested

  50. Slide 50: Operating Excellence

    Operating Excellence

  51. Slide 51: Operating Excellence

    Operating Excellence It is not only what we do but how we do it that is important our continued success The Molina Playbook Serving All Constituencies

  52. Slide 52: Our Performance Outlook

    Our Performance Outlook

  53. Slide 53: Performance Outlook

    Performance Outlook Our strategy will produce sustainable, profitable growth and industry leading margins What We Will Do ~ The Next 3 Years T% - 9% 87.5% - 88.5% 11% - 13% Organic Growth Medical Cost Ratio Earnings Growth Zs <T%h ~2% Acquisitions G&A Ratio Share Repurchases ...while continually ref

  54. Slide 54: Investment Thesis

    oy ie, Investment Thesis we Shareholder value is driven by strong growth, sustained margins and disciplined capital management Pure play government sponsored healthcare Attractive margins and operating leverage Legacy and new market opportunities High return capital deployment Double digit revenue g

  55. Slide 55: Compelling Financial Profile

    * em MOLINA nh HEALTHCARE Compelling Financial Profile Mark Keim Chief Financial Officer

  56. Slide 56: Compelling Financial Profile

    Compelling Financial Profile Molina Margin Mechanics ag Capital Foundation 2024 Guidance FAW Long-Term Financial Targets 2 Bed 2025 Outlook Aly investment Thesis

  57. Slide 57: Molina Margin Mechanics

    Molina Margin Mechanics

  58. Slide 58: Industry-leading Medicaid MCRs

    Industry-leading Medicaid MCRs Molina consistently outperforms peers due to disciplined medical cost management Medicaid MCR's (Statutory) 28% ~ Rates are established at the market level...each 26% te 3% a MCO gets the same rates = ws 28% 95% is Corridors are established at the market level... = eac

  59. Slide 59: Medical Cost Management

    Medical Cost Management Numerous capabilities drive medical cost efficiencies with focus on high-acuity populations Operating Focus & Rik Caw ~ State-of-the-art medical economics platform ee lie ~ Utilization management — High-acuity care management ne — FFS and value-based contracting ~ Payment int

  60. Slide 60: Medicaid Margin Sustainability

    Medicaid Margin Sustainability Rate setting on total market population cost base provides Molina opportunity to continually drive MCR: outperformance Market Risk Pool ~ Cost trend included in rates as CMS requires rate setting to be actuarially sound Example Market MCRs ~ State actuarial processes s

  61. Slide 61: Risk Corridors

    Risk Corridors Medicaid risk corridor positions are a result of margin outperformance and help mitigate potential inflections in medical cost trends Risk Corridor Dynamics — Molina averaged ~200 basis points of risk corridor expense/protection over the past few years 88.7% — In 2024, risk corridors

  62. Slide 62: G&A Expense Management

    G&A Expense Management Continued expense management and operating leverage drive lower G&A ratio while building capabilities for continued outperformance Expense Management i+ Leveraging the Base = Building Capabilities — Fixed cost leverage 50% ~ Artificial intelligence Variab — Productivity gains

  63. Slide 63: 2024 Guidance

    2024 Guidance

  64. Slide 64: 2024 Guidance

    2024 Guidance Full year 2024 guidance is reaffirmed Current Premium Revenue $32.5B ~$38B ~$38B Adjusted EPS $20.88 223.50 > $23.50 MCR % 88.1% 88.2% 88.7% Medicaid: 88.7% 89.0% 90.0% Medicare 90.7% 88.0% 88.3% Marketplace 75.3% 78.0% 74.0% GBA % 7.2% 7.0% 6.8% Pre-tax Margin % 4.8% 4.6% 4.6% Share C

  65. Slide 65: Medicaid MCR: 2Q24 to 3Q24

    Medicaid MCR: 2Q24 to 3Q24 Adjusting for CA retro items, the Medicaid MCR decreased 10 basis points driven by new store improvements and rates and risk corridors offsetting higher trend 2.6% 90.8% 0.5% 90.5% TET] 10.3%) (0.5%) (1.9%) CA Retro Items = (0.2%) Legacy Medicaid (ex. CA retro) = 0.2% 2024

  66. Slide 66: Medicaid MCR: 3Q24 to 4Q24

    Medicaid MCR: 3Q24 to 4Q24 Adjusting for CA retro items, we expect the Medicaid MCR to decrease 100 basis points driven by new store improvements, known rates, and risk corridors offsetting moderating trend 90.5% (0.2%) (0.8%) (0.5%) Legacy Medicaid (ex. CA retro) = (0.8%) 3Q24MCR cA3Q New Store Rat

  67. Slide 67: Medicaid MCR: Full Year Guidance

    5 Medicaid MCR: Full Year Guidance - Increased MCR guidance driven by higher trend partially offset by rates and risk corridors ~3.0% 90.0% 89.0% ~ (1.5%) Legacy Medicaid (ex. CA retro) = 0.7% FY24 Guidance CARetroltems — New Store Rates Trend Corridors FY24 Guidance na 202s Gussance ‘so 1004 Earnin

  68. Slide 68: Medicaid Medical Cost Trend

    Me ‘aid Medical Cost Trend Full year 2024 trend is now expected to be 6% and reflects equal contribution from the acuity shift and core trend Medicaid Trend Progression =3% __ -6% ~6% 3% cae tend RE Acuity Shit Initial 2024 Core Trend+ Current 2024 Initial 2024 Current 2024 Net Trend Acuity Shift _—

  69. Slide 69: 2024 EPS Guidance

    < 2024 EPS Guidance We reaffirm guidance of at least $23.50 with Marketplace, G&A ratio, and NII offsetting higher MCR’s in Medicaid and Medicare 2$23.50 $23.50 r r-- ($0.75) $0.30) | $2.70 ($2.70) FY24 Marketplace = G&A Net Medicaid Q3cA Medicare FY24 ior Leverage Investment Retro Item Guidance Gui

  70. Slide 70: 2025 Outlook

    2025 Outlook

  71. Slide 71: Medicaid Rate Environment

    Medicaid Rate Environment The rate cycle is well-timed with 55% of premium renewing on January 1* ~ Known on-cycle rates were 4.5% in 3Q24 and 9% in 4Q24 — Off-cycle rates were 1.5% in 3Q24 Core Rates ~ 55% of revenues reset January 1° — Known January rates are in draft form ~ We continue to expect

  72. Slide 72: 2025 Premium Revenue Outlook

    2025 Premium Revenue Outlook Known building blocks provide current outlook of ~8% premium revenue growth nS one 2841 $1.1 ae me en 2024 2025 Current RFP Wins ConnectiCare Strategic Guidance Headwinds Footprint 4s 03024 Eanigs Cat Initiatives

  73. Slide 73: Realization of Embedded Earnings

    Realization of Embedded Earnings Embedded earnings of $6.00 remain balanced between acquisitions and new contracts, with less than half expected to be realized in 2025 | omer | store oa aie $2.65 ($0.90) ($1.75) $3.35 ($1.10) ($2.25) ($2.00) ($4.00)

  74. Slide 74: 2025 Medicaid MCR Components

    2025 Medicaid MCR Components q Achieving the high-end of the long-term MCR target range requires 20 basis points of benefit off 2H 2024 guidance from the combination of rates, trend, and risk corridors 89.7% (0.3%) (0.2%) 2H 20246 CA 3024 New Store Rates Trend Risk High-End of LT Medicaid Retro Item

  75. Slide 75: 2025 Adjusted EPS Building Blocks

    2025 Adjusted EPS Building Blocks Medicaid margin is the largest driver of our outlook for current footprint and relies heavily on rates and trends $0.40 = $23.50 (2024 Current Embedded Share Repurchase Net Investment Guidance Footprint Earnings Benefit in 3024 Income 5 9084 Earn

  76. Slide 76: Capital Foundation

    Capital Foundation

  77. Slide 77: Strong Capital Foundation

    Strong Capital Foundation % Strong balance sheet provides foundation for stability and growth 3Q 2024 Credit Stats Reserve Strength Net Debt to EBITDA Ratio 14x Reserves at 9/30/24 $4.78 Net Debt / Capitalization ~35% Days in Claims Payable 48 Days Revolver Capacity $1,258 Recurring Parent Cash Flow

  78. Slide 78: Capital Deployment Discipline

    Capital Deployment Discipline Capital deployment is prioritized to opportunities with the highest returns Re-invest in Business “= Accretive Acquisitions Return to Shareholders |— Organic growth is the highest priority | Most efficient use of capital to. grow |— All ines of business are high growth

  79. Slide 79: Long-Term Financial Targets

    Long-Term Financial Targets

  80. Slide 80: Long-Term Targets

    Long-Term Targets Molina has a clear formula to deliver organic premium growth and sustainable MCR to achieve pre- tax margins Organic Medical Premium Cost Growth Ratio _ 5% with Marketplace Optionality ighted Total Medical Care Ratio Adj.G&A Ratio Pre-Tax Margin

  81. Slide 81: 2027 Premium Revenue Target

  82. Slide 82: 2027 Strategic Initiative Opportunity

  83. Slide 83: Long-Term EPS Growth

  84. Slide 84: Investment Thesis

  85. Slide 85: Performance Outlook

  86. Slide 86: Investment Thesis

  87. Slide 87: Q&A

  88. Slide 88: Reconciliation of Non-GAAP Financial Measures

Molina Healthcare — Investor Day (November 2024) on 6ix